IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

LINDA Y CALLAGHAN

Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry

NPI
1477768786
CMS profile
338972
Location
WASHINGTON, IN

General Payments · PY2018–2024

$2,970.12

  • Reported across 203 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$885.45

54 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Psychiatry IN All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $884.25 53
Education $1.20 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Vanda Pharmaceuticals Inc. $169.33 9
Alkermes, Inc. $140.54 13
Teva Pharmaceuticals USA, Inc. $128.07 7
Otsuka America Pharmaceutical, Inc. $100.13 6
Supernus Pharmaceuticals, Inc. $85.04 3
IRONSHORE PHARMACEUTICALS INC. $73.41 4
Corium, Inc. $39.13 4
BioXcel Therapeutics, Inc. $38.08 2
ITI, Inc. $37.44 2
E.R. Squibb & Sons, L.L.C. $31.40 2
Neurocrine BioSciences, Inc. $23.83 1
Lundbeck LLC $19.05 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $132.91 7
PY2019 $176.38 12
PY2020 $164.87 13
PY2021 $454.78 30
PY2022 $376.02 29
PY2023 $779.71 58
PY2024 $885.45 54

Payment records · PY2024 (54)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Alkermes, Inc. $4.86 03/18/2024 Food and Beverage Undisputed 01/23/2026 1120475086 CMS
Alkermes, Inc. $9.71 05/16/2024 Food and Beverage Undisputed 01/23/2026 1120475088 CMS
Alkermes, Inc. $15.44 05/20/2024 Food and Beverage Undisputed 01/23/2026 1120475090 CMS
Alkermes, Inc. $3.79 06/10/2024 Food and Beverage Undisputed 01/23/2026 1120475092 CMS
Alkermes, Inc. $21.44 07/15/2024 Food and Beverage Undisputed 01/23/2026 1120475094 CMS
Alkermes, Inc. $12.75 08/08/2024 Food and Beverage Undisputed 01/23/2026 1120475096 CMS
Alkermes, Inc. $5.50 09/26/2024 Food and Beverage Undisputed 01/23/2026 1120475098 CMS
Alkermes, Inc. $11.09 10/03/2024 Food and Beverage Undisputed 01/23/2026 1120475100 CMS
Alkermes, Inc. $12.22 10/23/2024 Food and Beverage Undisputed 01/23/2026 1120475102 CMS
Alkermes, Inc. $16.29 11/12/2024 Food and Beverage Undisputed 01/23/2026 1120475104 CMS
Alkermes, Inc. $7.48 11/20/2024 Food and Beverage Undisputed 01/23/2026 1120475106 CMS
Alkermes, Inc. $7.80 12/03/2024 Food and Beverage Undisputed 01/23/2026 1120475108 CMS
Alkermes, Inc. $12.17 12/05/2024 Food and Beverage Undisputed 01/23/2026 1120475110 CMS
BioXcel Therapeutics, Inc. $24.53 12/20/2024 Food and Beverage Undisputed 01/23/2026 1150028692 CMS
BioXcel Therapeutics, Inc. $13.55 12/21/2024 Food and Beverage Undisputed 01/23/2026 1150028694 CMS
Corium, LLC $16.07 04/05/2024 Food and Beverage Undisputed 01/23/2026 1100110030 CMS
Corium, LLC $2.30 04/05/2024 Food and Beverage Undisputed 01/23/2026 1100136042 CMS
Corium, LLC $16.54 05/31/2024 Food and Beverage Undisputed 01/23/2026 1100108644 CMS
Corium, LLC $4.22 06/11/2024 Food and Beverage Undisputed 01/23/2026 1100144132 CMS
E.R. Squibb & Sons, L.L.C. $16.26 11/07/2024 Food and Beverage Undisputed 01/23/2026 1101243488 CMS
E.R. Squibb & Sons, L.L.C. $15.14 12/16/2024 Food and Beverage Undisputed 01/23/2026 1101243500 CMS
IRONSHORE PHARMACEUTICALS INC. $17.62 01/17/2024 Food and Beverage Undisputed 01/23/2026 1146277440 CMS
IRONSHORE PHARMACEUTICALS INC. $20.23 03/20/2024 Food and Beverage Undisputed 01/23/2026 1146277544 CMS
IRONSHORE PHARMACEUTICALS INC. $13.56 05/29/2024 Food and Beverage Undisputed 01/23/2026 1146277630 CMS
IRONSHORE PHARMACEUTICALS INC. $22.00 08/07/2024 Food and Beverage Undisputed 01/23/2026 1146297888 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $14.47 02/07/2024 Food and Beverage Undisputed 01/23/2026 1143201962 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $22.97 12/19/2024 Food and Beverage Undisputed 01/23/2026 1143201966 CMS
Lundbeck LLC $19.05 04/16/2024 Food and Beverage Undisputed 01/23/2026 1145902050 CMS
Neurocrine Biosciences, Inc. $23.83 07/01/2024 Food and Beverage Undisputed 01/23/2026 1150843680 CMS
Otsuka America Pharmaceutical, Inc. $17.33 01/08/2024 Food and Beverage Undisputed 01/23/2026 1118870170 CMS
Otsuka America Pharmaceutical, Inc. $15.00 03/11/2024 Food and Beverage Undisputed 01/23/2026 1118870172 CMS
Otsuka America Pharmaceutical, Inc. $16.45 08/15/2024 Food and Beverage Undisputed 01/23/2026 1118870174 CMS
Otsuka America Pharmaceutical, Inc. $17.69 09/19/2024 Food and Beverage Undisputed 01/23/2026 1118870176 CMS
Otsuka America Pharmaceutical, Inc. $18.29 10/28/2024 Food and Beverage Undisputed 01/23/2026 1118870178 CMS
Otsuka America Pharmaceutical, Inc. $15.37 11/13/2024 Food and Beverage Undisputed 01/23/2026 1118870180 CMS
Supernus Pharmaceuticals, Inc. $45.88 01/18/2024 Food and Beverage Undisputed 01/23/2026 1147859109 CMS
Supernus Pharmaceuticals, Inc. $21.00 01/24/2024 Food and Beverage Undisputed 01/23/2026 1147859107 CMS
Supernus Pharmaceuticals, Inc. $18.16 07/03/2024 Food and Beverage Undisputed 01/23/2026 1147817258 CMS
Teva Pharmaceuticals USA, Inc. $16.11 01/25/2024 Food and Beverage Undisputed 01/23/2026 1151574943 CMS
Teva Pharmaceuticals USA, Inc. $15.80 01/30/2024 Food and Beverage Undisputed 01/23/2026 1151574945 CMS
Teva Pharmaceuticals USA, Inc. $17.51 03/06/2024 Food and Beverage Undisputed 01/23/2026 1151574947 CMS
Teva Pharmaceuticals USA, Inc. $21.88 03/25/2024 Food and Beverage Undisputed 01/23/2026 1151574961 CMS
Teva Pharmaceuticals USA, Inc. $20.58 04/12/2024 Food and Beverage Undisputed 01/23/2026 1151574965 CMS
Teva Pharmaceuticals USA, Inc. $22.16 06/20/2024 Food and Beverage Undisputed 01/23/2026 1151574971 CMS
Teva Pharmaceuticals USA, Inc. $14.03 10/31/2024 Food and Beverage Undisputed 01/23/2026 1151575085 CMS
Vanda Pharmaceuticals Inc. $10.82 07/30/2024 Food and Beverage Undisputed 01/23/2026 1133898625 CMS
Vanda Pharmaceuticals Inc. $21.62 08/07/2024 Food and Beverage Undisputed 01/23/2026 1133898627 CMS
Vanda Pharmaceuticals Inc. $12.60 09/05/2024 Food and Beverage Undisputed 01/23/2026 1133898629 CMS
Vanda Pharmaceuticals Inc. $9.09 09/18/2024 Food and Beverage Undisputed 01/23/2026 1133898631 CMS
Vanda Pharmaceuticals Inc. $30.60 10/09/2024 Food and Beverage Undisputed 01/23/2026 1133898633 CMS
Vanda Pharmaceuticals Inc. $35.62 10/29/2024 Food and Beverage Undisputed 01/23/2026 1133898635 CMS
Vanda Pharmaceuticals Inc. $1.20 11/14/2024 Education Undisputed 01/23/2026 1133898637 CMS
Vanda Pharmaceuticals Inc. $20.33 11/19/2024 Food and Beverage Undisputed 01/23/2026 1133898639 CMS
Vanda Pharmaceuticals Inc. $27.45 12/10/2024 Food and Beverage Undisputed 01/23/2026 1133898641 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.